Location History:
- Paris, FR (2015 - 2018)
- Vicq, FR (2013 - 2019)
Company Filing History:
4 out of 5,076 
2 out of 1,743 
2 out of 67 
Years Active: 2013-2019
Title: The Innovative Mind of Jocelyne Caboche
Introduction: Jocelyne Caboche, a prominent inventor based in Vicq, France, has made significant contributions to the field of biomedical research. With four patents to her name, she has established herself as a leader in developing innovative solutions for health-related challenges. Her work primarily focuses on the inhibition of cellular pathways that play crucial roles in cancer and other diseases.
Latest Patents: Jocelyne Caboche’s latest patents demonstrate her expertise in the MAP kinase/ERK signaling pathway. One of her notable inventions includes "Inhibitor Peptides of ERK-type MAP kinase," which presents peptides designed to act as specific inhibitors of the MAP kinase/ERK pathway concerning a particular substrate in a designated subcellular compartment. Additionally, she has developed "Selective Inhibitors of c-Fos and Their Antiproliferative Properties," which relates to the prevention and treatment of cancers and restenosis through the use of selective c-Fos inhibitors.
Career Highlights: Throughout her career, Jocelyne has been associated with prestigious research institutions, such as the Centre National de la Recherche Scientifique (CNRS) and the Institut National de la Santé et de la Recherche Médicale (INSERM). Her work in these organizations has been instrumental in broadening the understanding of cancer biology and therapeutic interventions.
Collaborations: Jocelyne has collaborated with distinguished colleagues, including Peter Vanhoutte and Patrick Aubourg. These partnerships have fostered innovative research and accelerated the development of her groundbreaking inventions.
Conclusion: Jocelyne Caboche’s contributions to science and medicine underscore the importance of innovation in tackling pressing health issues. Her patents not only reflect her creativity and expertise as an inventor but also her commitment to improving patient outcomes through research and development. As she continues to expand her work, the impact of her inventions will undoubtedly resonate within the scientific community and beyond.